Moderna Looks To mRNA To Crack Challenge Of HIV Vaccine

mRNA Will Speed Development Time

The Bill Gates Foundation-backed partnership with IAVI could bring a HIV vaccine a step closer, but generating the right antibody response has defeated many previous attempts.

Moderna believes its mRNA know-how, which has proven so successful against COVID-19, could also help finally crack the challenge of developing a HIV vaccine, and has just launched a Phase I study with academic partners.

While antiretroviral therapies are able to suppress HIV for a lifetime once individuals are infected, there remains a need for...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip